Trevena to Present at the H.C. Wainwright Global Investment Conference
18.05.2022 - CHESTERBROOK, Pa., May 18, 2022 (GLOBE NEWSWIRE) - Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today ...